Literature DB >> 12033920

Plasminogen activation is stimulated by prion protein and regulated in a copper-dependent manner.

Vincent Ellis1, Maki Daniels, Rashmi Misra, David R Brown.   

Abstract

Prion diseases are associated with the conversion of the normal prion protein, PrP(C), to the infectious disease form PrP(Sc). Discrimination between these isoforms would significantly enhance diagnosis of these diseases, and it has recently been reported that PrP(Sc) is specifically recognized by the serine protease zymogen plasminogen (Fischer et al. (2000) Nature 408, 479). Here we have tested the hypothesis that PrP is a regulator of the plasminogen activation system. The effect of recombinant PrP, either containing copper (holo-PrP) or devoid of it (apo-PrP), on plasminogen activation by both uPA and tPA was determined. PrP had no effect on plasminogen activation by uPA. By contrast, the activity of tPA was stimulated by up to 280-fold. This was observed only with the apo-PrP isoforms. The copper-binding octapeptide repeat region of PrP was involved in the effects, as a mutant lacking this region failed to stimulate plasminogen activation, although a synthetic peptide corresponding to this region was unable to stimulate tPA activity. Competition experiments demonstrated that, in addition to plasminogen binding, the stimulation required a high-affinity interaction between tPA and PrP (K(d) < 2.5 nM). Kinetic analysis revealed a template mechanism for the stimulation, suggesting independent binding sites for tPA and plasminogen. Lack of copper-binding may be an early event in the conversion of PrP(C) to PrP(Sc), and our data therefore suggest that tPA-catalyzed plasminogen activation may provide the basis for a sensitive detection system for the early stages of prion diseases and also play a role in the pathogenesis of these diseases.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12033920     DOI: 10.1021/bi025676g

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  21 in total

1.  Plasminogen: A cellular protein cofactor for PrPSc propagation.

Authors:  Charles E Mays; Chongsuk Ryou
Journal:  Prion       Date:  2011-01-01       Impact factor: 3.931

2.  Recombinant prion protein does not possess SOD-1 activity.

Authors:  Samantha Jones; Mark Batchelor; Daljit Bhelt; Anthony R Clarke; John Collinge; Graham S Jackson
Journal:  Biochem J       Date:  2005-12-01       Impact factor: 3.857

3.  Amorphous protein aggregates stimulate plasminogen activation, leading to release of cytotoxic fragments that are clients for extracellular chaperones.

Authors:  Patrick Constantinescu; Rebecca A Brown; Amy R Wyatt; Marie Ranson; Mark R Wilson
Journal:  J Biol Chem       Date:  2017-07-14       Impact factor: 5.157

4.  Comparison of inflammatory and acute-phase responses in the brain and peripheral organs of the ME7 model of prion disease.

Authors:  Colm Cunningham; David C Wilcockson; Delphine Boche; V Hugh Perry
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

Review 5.  Desmoteplase: discovery, insights and opportunities for ischaemic stroke.

Authors:  Robert L Medcalf
Journal:  Br J Pharmacol       Date:  2012-01       Impact factor: 8.739

6.  Canine plasminogen: spectral responses to changes in 6-aminohexanoate and temperature.

Authors:  Jack A Kornblatt; Tanya A Barretto; Ketevan Chigogidze; Bahati Chirwa
Journal:  Anal Chem Insights       Date:  2007-03-22

7.  Intravenous desmoteplase in patients with acute ischaemic stroke selected by MRI perfusion-diffusion weighted imaging or perfusion CT (DIAS-2): a prospective, randomised, double-blind, placebo-controlled study.

Authors:  Werner Hacke; Anthony J Furlan; Yasir Al-Rawi; Antoni Davalos; Jochen B Fiebach; Franz Gruber; Markku Kaste; Leslie J Lipka; Salvador Pedraza; Peter A Ringleb; Howard A Rowley; Dietmar Schneider; Lee H Schwamm; Joaquin Serena Leal; Mariola Söhngen; Phil A Teal; Karin Wilhelm-Ogunbiyi; Max Wintermark; Steven Warach
Journal:  Lancet Neurol       Date:  2008-12-25       Impact factor: 44.182

8.  Cryptic peptides of the kringle domains preferentially bind to disease-associated prion protein.

Authors:  Kristen Hatcher; Jian Zheng; Shu G Chen
Journal:  J Alzheimers Dis       Date:  2009       Impact factor: 4.472

9.  Changes in gene expression of kringle domain-containing proteins in murine brains and neuroblastoma cells infected by prions.

Authors:  Younghwan Kim; Jihyun Song; Charles E Mays; William Titlow; Donghoon Yoon; Chongsuk Ryou
Journal:  Mol Cell Biochem       Date:  2009-03-26       Impact factor: 3.396

10.  Microglia and the urokinase plasminogen activator receptor/uPA system in innate brain inflammation.

Authors:  Orla Cunningham; Suzanne Campion; V Hugh Perry; Carol Murray; Nicolai Sidenius; Fabian Docagne; Colm Cunningham
Journal:  Glia       Date:  2009-12       Impact factor: 7.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.